1-20 of 30
Charles G. Drake
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT137: Efficacy and immunological outcomes of non-fucosylated anti-CTLA-4 (BMS-986218) + degarelix acetate vs. degarelix acetate alone in men with high-risk localized prostate cancer (Neo-Red-P)

Free
Patrick J. McCann, Casey R. Ager, Aleksandar Z. Obradovic, Matthew G. Chaimowitz, Samuel Pan, Caroline J. Laplaca, Parin Shah, Renu K. Virk, Christopher B. Anderson, Catherine S. Spina, Karie D. Runcie, Mark N. Stein, Charles G. Drake, Matthew C. Dallos
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT137.
https://doi.org/10.1158/1538-7445.AM2024-CT137
Published: 05 April 2024
View articletitled, Abstract CT137: Efficacy and immunological outcomes of non-fucosylated anti-CTLA-4 (BMS-986218) + degarelix acetate vs. degarelix acetate alone in men with high-risk localized prostate cancer (Neo-Red-P)
Journal Articles

Abstract 933: Single-cell inference and validation of heterogeneous drug sensitivity in cholangiocarcinoma reveals dacinostat as novel therapeutic candidate

Free
Aleksandar Obradovic, Lorenzo Tomassoni, Daoqi Yu, Charles G. Drake, FIlemon Dela Cruz, Andrew Kung, Andrea Califano
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 933.
https://doi.org/10.1158/1538-7445.AM2024-933
Published: 22 March 2024
View articletitled, Abstract 933: Single-cell inference and validation of heterogeneous drug sensitivity in cholangiocarcinoma reveals dacinostat as novel therapeutic candidate
Journal Articles

Abstract PR009: SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion

Free
Giuseppe Leuzzi, Alessandro Vasciaveo, Angelo Taglialatela, Xiao Chen, Tessa M. Firestone, Allison R. Hickman, Wendy Mao, Tanay Thakar, Alina Vaitsiankova, Jen-Wei Huang, Raquel Cuella-Martin, Samuel B. Hayward, Jordan S. Kesner, Ali Ghasemzadeh, Tarun S. Nambiar, Patricia Ho, Alexander Rialdi, Maxime Hebrard, Yinglu Li, Jinmei Gao, Saarang Gopinath, Oluwatobi A. Adeleke, Bryan Venters, Charles G. Drake, Richard Baer, Benjamin Izar, Ernesto Guccione, Michael-Christopher Keogh, Raphael Guerois, Lu Sun, Chao Lu, Andrea Califano, Alberto Ciccia
Journal: Cancer Research
Cancer Res (2024) 84 (1_Supplement): PR009.
https://doi.org/10.1158/1538-7445.DNAREPAIR24-PR009
Published: 09 January 2024
View articletitled, Abstract PR009: SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
Journal Articles

Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC)

Free
Patrick J. McCann, Wendy Mao, Matthew Chaimowitz, Erika Houthys, Reece Marillier, Shruti Bansal, Julia An, Jason A. Piersaint, Namita Sen, Charles G. Drake, Catherine S. Spina
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): B032.
https://doi.org/10.1158/1538-7445.PRCA2023-B032
Published: 02 June 2023
View articletitled, Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC)
Journal Articles

Abstract 4115: KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with immune escape and immunotherapy response

Free
Casey Ager, Matthew Chaimowitz, Shruti Bansal, Meri Rogava, Johannes Melms, Catherine Spina, Cory Abate-Shen, Charles G. Drake, Matthew Dallos, Benjamin Izar
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4115.
https://doi.org/10.1158/1538-7445.AM2023-4115
Published: 04 April 2023
View articletitled, Abstract 4115: KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with immune escape and immunotherapy response
Journal Articles

Abstract 3612: Elucidating and targeting master regulators of tumor infiltrating regulatory T cells

Free
Casey R. Ager, Aleksandar Obradovic, Mikko Turunen, Mohsen Khosravi-Maharlooei, Charles Karan, Andrea Califano, Charles G. Drake
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3612.
https://doi.org/10.1158/1538-7445.AM2022-3612
Published: 15 June 2022
View articletitled, Abstract 3612: Elucidating and targeting master regulators of tumor infiltrating regulatory T cells
Journal Articles

Abstract 1794: Human cancer associated fibroblast subsets can differentially regulate immunotherapy response in head and neck cancer patients

Free
Diana Graves, Michael J. Korrer, Aleksandar Z. Obradovic, Sohini Roy, Andrea Califano, Charles G. Drake, Young J. Kim
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1794.
https://doi.org/10.1158/1538-7445.AM2021-1794
Published: 01 July 2021
View articletitled, Abstract 1794: Human cancer associated fibroblast subsets can differentially regulate immunotherapy response in head and neck cancer patients
Journal Articles

A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer

Available to Purchase
Tamas A. Gonda, Jarwei Fang, Martha Salas, Catherine Do, Emily Hsu, Anna Zhukovskaya, Ariel Siegel, Ryota Takahashi, Zoila A. Lopez-Bujanda, Charles G. Drake, Gulam A. Manji, Timothy C. Wang, Kenneth P. Olive, Benjamin Tycko
Journal: Cancer Research
Cancer Res (2020) 80 (21): 4754–4767.
https://doi.org/10.1158/0008-5472.CAN-20-0285
Published: 03 November 2020
View articletitled, A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Open the PDF for A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PO-024: Tumor-specific cell populations in clear cell renal carcinoma associated with clinical outcome identified using single-cell protein activity inference

Free
Aleksandar Obradovic, Nivedita Showdhury, Casey Ager, Vinson Wang, Lukas Vlahos, Xinzheng V. Guo, David H. Aggen, James McKiernan, Andrea Califano, Charles G. Drake
Journal: Cancer Research
Cancer Res (2020) 80 (21_Supplement): PO-024.
https://doi.org/10.1158/1538-7445.TUMHET2020-PO-024
Published: 03 November 2020
View articletitled, Abstract PO-024: Tumor-specific cell populations in clear cell renal carcinoma associated with clinical outcome identified using single-cell protein activity inference
Journal Articles

Abstract B11: Prognostic biomarkers in stage II-III melanoma

Free
Emanuelle M. Rizk, Robyn D. Gartrell, Andrew Chen, Rui Chang, Douglas K. Marks, Camden L. Esancy, Bret Taback, Basil A. Horst, Charles G. Drake, Raul Rabadan, Yvonne M. Saenger
Journal: Cancer Research
Cancer Res (2020) 80 (19_Supplement): B11.
https://doi.org/10.1158/1538-7445.MEL2019-B11
Published: 02 October 2020
View articletitled, Abstract B11: Prognostic biomarkers in stage II-III melanoma
Journal Articles

Abstract 4491: Characterizing long non-coding RNA expression of tumor-infiltrating lymphocytes across solid cancers

Free
Wikum Dinalankara, Eddie-Luidy Imada, Christopher M. Jackson, Thomas R. Nirschl, Michael Lim, Charles G. Drake, Luigi Marchionni
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4491.
https://doi.org/10.1158/1538-7445.AM2020-4491
Published: 15 August 2020
View articletitled, Abstract 4491: Characterizing long non-coding RNA expression of tumor-infiltrating lymphocytes across solid cancers
Journal Articles

Abstract CT026: Evidence of immune activation in the first-in-human Phase Ia dose escalation study of the adenosine 2a receptor antagonist, AZD4635, in patients with advanced solid tumors

Free
Johanna Bendell, Todd Bauer, Manish Patel, Gerald Falchook, Janet L. Karlix, Emerson Lim, Ganesh Mugundu, Patrick D. Mitchell, Gayle P. Pouliot, Ganesh Moorthy, Bolan Linghu, Lara McGrath, Bryony Harrop, Wenlin Shao, Charles G. Drake, Kris Sachsenmeier, Melinda S. Merchant
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT026.
https://doi.org/10.1158/1538-7445.AM2019-CT026
Published: 01 July 2019
View articletitled, Abstract CT026: Evidence of immune activation in the first-in-human Phase Ia dose escalation study of the adenosine 2a receptor antagonist, AZD4635, in patients with advanced solid tumors
Journal Articles

Abstract 1476: Decoding the immunologic landscape of human clear cell renal carcinoma

Free
Nivedita Chowdhury, Aleksandar Obradovic, David Aggen, Vinson Wang, Xinzheng Guo, Guarionex J. DeCastro, Hongxu Ding, Andrea Califano, Charles G. Drake
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1476.
https://doi.org/10.1158/1538-7445.AM2019-1476
Published: 01 July 2019
View articletitled, Abstract 1476: Decoding the immunologic landscape of human clear cell renal carcinoma
Journal Articles

Abstract 1510: Androgen regulated IL-8 expression in prostate cancer: Insights into tumor cell mediated immunosuppression

Free
Zoila A. Lopez Bujanda, Michael C. Haffner, Matthew G. Chaimowitz, Nivedita Chowdhury, Paula J. Hurley, Angela M. Christiano, Charles G. Drake
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1510.
https://doi.org/10.1158/1538-7445.AM2019-1510
Published: 01 July 2019
View articletitled, Abstract 1510: Androgen regulated IL-8 expression in prostate cancer: Insights into tumor cell mediated immunosuppression
Journal Articles

Abstract LB-118: A conserved checkpoint molecule signature offers novel targets for tumor specific regulatory T cell manipulation

Free
Zachary T. Freeman, Daniel H. Hovleson, Alexander T. Pearson, Jingyi Zhai, Ali Ghasemzadeh, Thomas R. Nirschl, Hui Jiang, Scott A. Tomlins, Charles G. Drake
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-118.
https://doi.org/10.1158/1538-7445.AM2018-LB-118
Published: 01 July 2018
View articletitled, Abstract LB-118: A conserved checkpoint molecule signature offers novel targets for tumor specific regulatory T cell manipulation
Journal Articles

Abstract 2091: Quantitative compositional and spatial analysis of tumor microenvironment (TME) in primary melanoma

Free
Robyn D. Gartrell, Andrew Chen, Douglas K. Marks, Thomas D. Hart, Gen Li, Alan Wu, Yan Lu, Camden Esancy, Zoe Blake, Bret Taback, Raul Rabadan, Howard L. Kaufman, Charles G. Drake, Basil Horst, Anthea Monod, Yvonne Saenger
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2091.
https://doi.org/10.1158/1538-7445.AM2018-2091
Published: 01 July 2018
View articletitled, Abstract 2091: Quantitative compositional and spatial analysis of tumor microenvironment (TME) in primary melanoma
Journal Articles

Abstract 812: Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to finasteride in the Prostate Cancer Prevention Trial

Free
Danyelle A. Winchester, Cathee Till, Jianfeng Xu, Ian M. Thompson, Scott M. Lippmann, Howard L. Parnes, Angelo M. De Marzo, Charles G. Drake, Elizabeth A. Platz, The PCPT P01 Project 4 Research Team
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 812.
https://doi.org/10.1158/1538-7445.AM2016-812
Published: 15 July 2016
View articletitled, Abstract 812: Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to finasteride in the Prostate Cancer Prevention Trial
Journal Articles

Abstract 267: Combining androgen deprivation with immune checkpoint blockade delays the development of castration resistance in a murine model of prostate cancer

Free
Ying-Chun Shen, Christina Kochel, Brian J. Francica, Angela Alme, Christopher Nirschl, Thomas Nirschl, Zoila Areli Lopez Bujanda, Maria A. Carrera H, Mark Selby, Alan Korman, Charles G. Drake
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 267.
https://doi.org/10.1158/1538-7445.AM2015-267
Published: 01 August 2015
View articletitled, Abstract 267: Combining androgen deprivation with immune checkpoint blockade delays the development of castration resistance in a murine model of prostate cancer
Journal Articles

Abstract 4605: Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Free
Danyelle A. Winchester, Cathee Till, Phyllis J. Goodman, Catherine M. Tangen, Regina M. Santella, Teresa L. Johnson-Pais, Robin J. Leach, Jianfeng Xu, S. Lilly Zheng, Ian M. Thompson, M. Scott Lucia, Scott M. Lippmann, Howard L. Parnes, Paul J. Dluzniewski, William B. Isaacs, Angelo M. De Marzo, Charles G. Drake, Elizabeth A. Platz
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4605.
https://doi.org/10.1158/1538-7445.AM2015-4605
Published: 01 August 2015
View articletitled, Abstract 4605: Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
Journal Articles

Enhancement of the T-cell Armamentarium as a Cell-Based Therapy for Prostate Cancer

Free
W. Nathaniel Brennen, Charles G. Drake, John T. Isaacs
Journal: Cancer Research
Cancer Res (2014) 74 (13): 3390–3395.
https://doi.org/10.1158/0008-5472.CAN-14-0249
Published: 30 June 2014
View articletitled, Enhancement of the T-cell Armamentarium as a Cell-Based Therapy for Prostate Cancer
Open the PDF for Enhancement of the T-cell Armamentarium as a Cell-Based Therapy for Prostate Cancer in another window